Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
The Lancet. Oncology|September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trialYoshie Umemura, Daniel Orringer, Larry Junck, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
Research Square|September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic TargetFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Neuro-Oncology|May 23, 2022
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline gliomaDana Messinger, Micah K Harris, Jessica R Cummings, et al.
Science Translational Medicine|February 15, 2019
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage responseFelipe J Núñez, Flor M Mendez, Padma Kadiyala, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Oncoimmunology|May 6, 2015
Consensus guidelines for the detection of immunogenic cell deathOliver Kepp, Laura Senovilla, Ilio Vitale, et al.
Pageof 21